Prevention of recurrent urinary-tract infections in women
- 1 January 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9146) , 7-8
- https://doi.org/10.1016/s0140-6736(05)74875-3
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The Globoseries Glycosphingolipid Sialosyl Galactosyl Globoside Is Found in Urinary Tract Tissues and Is a Preferred Binding Receptor In Vitro for Uropathogenic Escherichia coli Expressing pap -Encoded AdhesinsInfection and Immunity, 1998
- Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.Journal of Clinical Investigation, 1998
- Antecedent Antimicrobial Use Increases the Risk of Uncomplicated Cystitis in Young WomenClinical Infectious Diseases, 1997
- A Prospective Study of Risk Factors for Symptomatic Urinary Tract Infection in Young WomenNew England Journal of Medicine, 1996
- Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli.The Journal of Experimental Medicine, 1996
- Epithelial cytokine responses and mucosal cytokine networksTrends in Microbiology, 1995
- Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status.Journal of Clinical Investigation, 1992
- Virulence factors in Escherichia coli urinary tract infectionClinical Microbiology Reviews, 1991
- Recurring urinary tract infection: incidence and risk factors.American Journal of Public Health, 1990
- Association of in VitroEscherichia coliAdherence to Vaginal and Buccal Epithelial Cells with Susceptibility of Women to Recurrent Urinary-Tract InfectionsNew England Journal of Medicine, 1981